Horizon Therapeutics PLC (HZNP) Social Stream



Horizon Therapeutics PLC (HZNP): $98.48

-6.37 (-6.08%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

HORIZON THERAPEUTICS PUBLIC LTD CO (HZNP) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering HORIZON THERAPEUTICS PUBLIC LTD CO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-30 9 $155 $107 $134.1 $78.76 70.26%
2021-12-08 10 $155 $107 $134.363 $78.76 70.6%
2022-01-06 10 $156 $107 $135.272 $78.76 71.75%
2022-01-18 10 $155 $107 $135.09 $78.76 71.52%
2022-03-01 10 $155 $107 $134.181 $78.76 70.37%
2022-03-02 10 $155 $107 $134.636 $78.76 70.94%
2022-05-02 11 $155 $121 $137.727 $78.76 74.87%
2022-05-03 11 $155 $121 $137.636 $78.76 74.75%
2022-05-05 11 $155 $121 $137 $78.76 73.95%
2022-06-06 12 $155 $95 $133.5 $78.76 69.5%
2022-06-14 13 $155 $95 $133.923 $78.76 70.04%
2022-07-14 12 $155 $95 $133.692 $78.76 69.75%
2022-08-03 12 $155 $95 $132.923 $78.76 68.77%
2022-08-04 14 $144 $71 $107.846 $78.76 36.93%
2022-09-06 13 $144 $71 $107.846 $78.76 36.93%
2022-10-14 13 $144 $71 $107.769 $78.76 36.83%
2022-10-19 13 $144 $71 $107.692 $78.76 36.73%
2022-10-25 13 $144 $71 $107.538 $78.76 36.54%
2022-11-01 14 $144 $71 $105.142 $78.76 33.5%
2022-11-02 14 $144 $71 $105.214 $78.76 33.59%
2022-11-03 14 $144 $71 $106.357 $78.76 35.04%

The Trend in the Analyst Price Target


Over the past 29 months, HZNP's average price target has gone up $53.03.

HZNP reports an average of 53.89% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-13 11 155 121 137.727 115.15 19.61%
2022-09-06 13 144 71 107.846 59.63 80.86%
2022-10-11 13 144 71 107.769 63.62 69.39%
2022-10-14 13 144 71 107.692 62.51 72.28%
2022-10-25 13 144 71 107.538 66.13 62.62%

HZNP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.32 11 1 2 0 0 14

The Trend in the Broker Recommendations


HZNP's average broker recommendation rating improved by 0.31 over the prior 13 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • HZNP has a higher average analyst price target than 1909.78% of all US stocks.
  • HZNP has a higher number of analysts covering the stock than 2009.62% of Pharmaceutical Products stocks.
  • In terms of how HORIZON THERAPEUTICS PUBLIC LTD CO fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 640.09% of that group.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, HORIZON THERAPEUTICS PUBLIC LTD CO's variance in analysts' estimates is lower than -1116.98% of them.

In the Pharmaceutical Products industry, JAZZ, BMRN, and VRTX are the three stocks most similar to HORIZON THERAPEUTICS PUBLIC LTD CO regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding HZNP using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5907 seconds.